Live Breaking News & Updates on Henrik semb

Stay informed with the latest breaking news from Henrik semb on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Henrik semb and stay connected to the pulse of your community

Researchers identify a new pathogenic mechanism for diabetes onset in MODY3

In order to treat patients with diabetes in the best possible way it is necessary to understand the disease mechanism. MODY type 3 (MODY3) is a monogenic hereditary form of diabetes, that is caused by a genetic defect in the HNF1A gene.

Munich , Bayern , Germany , Florian-hermann , Henrik-semb , Maya-kj , Emily-henderson , Institute-of-translational-stem-cell-research , Helmholtz-diabetes-center , Translational-stem-cell-research , Helmholtz-munich , Cell-stem

PANCRYOS ANNOUNCES EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR FIRST IN CLASS MACROENCAPSULATION DEVICE

/PRNewswire/ -- Pancryos today announced that it has executed a global exclusive license with Brigham and Women's Hospital for the first in class...

Denmark , Copenhagen , Køavn- , Danish , Brock-reeve , Randal-mckenzie , Jeff-karp , Henrik-semb , Jaime-giraldo , Jacqueline-ameri , Prnewswire-pancryos , University-of-copenhagen

PanCryos ApS: PANCRYOS ANNOUNCES EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR FIRST IN CLASS MACROENCAPSULATION DEVICE

Technology Will Enable Safe And Efficacious Delivery Of Pancryos' Stem Cell Derived Therapy For Treatment Of Type 1 Diabetes Visualization by Randal McKenzie COPENHAGEN, Denmark, May 24

Denmark , Copenhagen , Køavn- , Danish , Randal-mckenzie , Jeff-karp , Henrik-semb , Jacqueline-ameri , Prnewswire-pancryos , Brock-reeve , Kostenloser-wertpapierhandel , Jaime-giraldo

Human Strategy Series: Interview with Dr Jackie Ameri, CEO of Pancryos

“I like the excitement of not knowing what’s going to happen and I think I thrive on it.”For the first interview in our Human Strategy Series,  the team recently spoke with Dr Jackie Ameri, CEO of Pancryos, who benefited from our Leadership Assessment service as part of the partnership between...

Denmark , Copenhagen , Køavn- , Danish , James-thomson , Jackie-ameri , Henrik-semb , Jacqueline-ameri , Section-for-strategic-translational-stem-cell-research , Bioinnovation-institute , University-of-copenhagen , Lund-stem-cell-center

Diabetic patients? Human stem cells to produce insulin-producing cells for treatment

Diabetic patients? Human stem cells to produce insulin-producing cells for treatment
Diabetic patients? Human stem cells to produce insulin-producing cells for treatment
According To Reports, Over 415 Million People Have Been Diagnosed With Diabetes Globally. Diabetes Patients Lack The Ability To Produce Sufficient Amounts Of Insulin, Which Regulates The Blood Sugar In The Body. This Can Result In A Number Of Complications And In Many Cases Be Potentially Fatal.
News Nation Bureau | Edited By : Neha Singh
| Updated on: 08 Nov 2017, 02:47:48 PM
New Delhi:
Good News! In the new study, published in the Journal Nature Cell Biology, shows that Human stem cells can now be used to produce insulin-producing cells that can be transplanted into diabetes patients in future.

Denmark , Copenhagen , Køavn , New-delhi , Delhi , India , Henrik-semb , University-of-copenhagen , Journal-nature-cell-biology , Diabetes-treatment , Stem-cell-therapy , Stem-cells